MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

PRA Health Sciences Company Profile (NASDAQ:PRAH)

Consensus Ratings for PRA Health Sciences (NASDAQ:PRAH) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $47.44 (12.92% upside)

Analysts' Ratings History for PRA Health Sciences (NASDAQ:PRAH)
Show:
DateFirmActionRatingPrice TargetActions
6/20/2016First AnalysisInitiated CoverageEqual -> Equal Weight$47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2016Credit SuisseInitiated CoverageNeutral$43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2016KeyBancUpgradeSector Weight -> Overweight$55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Citigroup Inc.UpgradeNeutral -> Buy$51.00 -> $53.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016SunTrustUpgradeNeutral -> Buy$47.00 -> $51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Jefferies GroupBoost Price Target$49.50 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015Avondale PartnersDowngradeMarket Perform -> Underperform$31.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2015Robert W. BairdBoost Price TargetOutperform$47.00 -> $49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/21/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2014Wells FargoInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for PRA Health Sciences (NASDAQ:PRAH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/25/2016        
4/27/2016Q116$0.53$0.55$372.21 million$372.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2016Q4$0.49$0.59$353.42 million$428.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2015Q3$0.45$0.52$346.05 million$345.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/27/2015Q215$0.40$0.47$336.74 million$336.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q115$0.31$0.41$329.80 million$332.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/18/2015Q414$0.30$0.35$323.50 million$370.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for PRA Health Sciences (NASDAQ:PRAH)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.47$0.51$0.49
Q2 20162$0.56$0.59$0.58
Q3 20163$0.62$0.63$0.62
Q4 20162$0.63$0.69$0.66
(Data provided by Zacks Investment Research)
Dividend History for PRA Health Sciences (NASDAQ:PRAH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for PRA Health Sciences (NASDAQ:PRAH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/6/2016Linda BaddourCFOSell92,308$46.70$4,310,783.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Pra Investors L.P. KkrMajor ShareholderSell4,907,692$46.70$229,189,216.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/8/2016Colin ShannonCEOSell77,019$42.26$3,254,822.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/8/2016Linda BaddourCFOSell93,000$42.26$3,930,180.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/8/2016Pra Investors L.P. KkrMajor ShareholderSell4,829,981$42.26$204,114,997.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for PRA Health Sciences (NASDAQ:PRAH)
DateHeadline
06/22/16 05:54 PMCredit Suisse covered (NASDAQ:PRAH) PRA Health Sciences, increasing its stock price target to $43 earlier today
06/22/16 10:38 AMPRA Health Shares Initiated Neutral By Credit Suisse
06/21/16 05:29 PMPRA Health Sciences, Inc. Stock Momentum Hits Weakness - CML News
06/21/16 10:18 AMCredit Suisse Starts PRA Health Sciences (PRAH) at Neutral
06/20/16 07:29 AMStrong Buy Calls Count For PRA Health Sciences, Inc. (NASDAQ:PRAH) At 6 - Investor Newswire
06/20/16 07:29 AMKeyBanc Upgrades PRA Health Sciences Inc to Overweight - TheFounders Daily
06/17/16 05:43 PMPRA Health Sciences Becomes Oversold (PRAH)
06/17/16 08:00 AMPRA Health Sciences (PRAH) Is in Oversold Territory: What's Next? -
06/13/16 05:26 PMKeyBanc Expecting PRA Health Sciences To Beat Estimates, Upgrades To Overweight
06/13/16 01:50 PMPRA Health Sciences, Inc. – Value Analysis (NASDAQ:PRAH) : June 13, 2016 -
06/10/16 06:13 PMTrend Of Rating Given To PRA Health Sciences, Inc. (NASDAQ:PRAH) - Investor Newswire
06/10/16 07:20 AMPRA Health Sciences, Inc. breached its 50 day moving average in a Bearish Manner : PRAH-US : June 10, 2016 -
06/09/16 06:19 PMAnalysts Expect FPX Will Reach $60
06/07/16 06:08 PMPRA Health Sciences, Inc. (NASDAQ:PRAH) Earns Rating Score Of 1.33 - RealistInvestor.com
06/06/16 05:51 PMPRA HEALTH SCIENCES INC. (NASDAQ:PRAH) Financial Condition Compared to S&P 500 - CML News
06/02/16 03:08 PMPRA HEALTH SCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/01/16 08:51 AMStock Review and Earnings Check on PRA Health Sciences, Inc. (NASDAQ:PRAH) - HNN - Stock Review and Earnings Check on PRA Health Sciences, Inc. (NASDAQ:PRAH)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting PRA Health Sciences, Inc.and more »
05/29/16 11:53 AMPRA Health Sciences, Inc. (NASDAQ:PRAH) One-Year Price Target At $52.42 - Investor Newswire - PRA Health Sciences, Inc. (NASDAQ:PRAH) One-Year Price Target At $52.42Investor NewswireFirst Call has set a 52-week price target of $52.42 on PRA Health Sciences, Inc. (NASDAQ:PRAH) stock after completion of its survey. For the approaching quarter, EPS estimate is set at $0.63 and for underway fiscal at $2.43. This estimate for next year ...and more »
05/27/16 06:51 AMThese U.S. stocks will outperform if U.K. votes against Brexit -
05/26/16 11:20 AMBanks Ramp Up Risk With Big Trades to Help Companies Sell Stock - On Wednesday, Walgreens’s stock closed at $77.63. Wells Fargo WFC 2.64 % & Co. bought five million shares of PRA Health Sciences Inc. PRAH 0.88 % from selling shareholders on May 2 at a price of $46.70 a share, according to a regulatory filing.
05/20/16 07:44 AMWhy PRA Health Sciences (PRAH) Could Be an Impressive Growth Stock -
05/17/16 04:02 AMPRA Health Sciences Named International Clinical Research Company of the Year - [at noodls] - RALEIGH, N.C., May 17, 2016 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc., (PRA) (NASDAQ:PRAH) is pleased to announce that for the third consecutive year it was recognized as the Clinical Research Company ...
05/06/16 04:46 PMPRA HEALTH SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex -
05/05/16 05:41 AMPRA Health Sciences Named Clinical Research Company of the Year - [at noodls] - RALEIGH, N.C., April 18, 2016 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc., (PRA) (NASDAQ:PRAH) is pleased to announce it was once again recognized as the Best Clinical Research Company of the Year. PRA ...
05/05/16 05:41 AMPRA Health Sciences to Report First Quarter 2016 Earnings - [at noodls] - RALEIGH, N.C., April 15, 2016 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) will release its first quarter 2016 results after the market closes on Wednesday, April 27, 2016. The Company will ...
05/05/16 05:31 AMPRA Health Sciences, Inc. Reports First Quarter 2016 Results and Updates 2016 Guidance - [at noodls] - $372.3 million of service revenue in the first quarter; 13.0% constant currency growth compared to the first quarter of 2015 First quarter GAAP Net Loss of $16.0 million or $0.27 per diluted share, which ...
05/05/16 05:31 AMPRA Health Sciences, Inc. Announces Secondary Offering of 5,000,000 Shares of Common Stock - [at noodls] - RALEIGH, N.C., May 02, 2016 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (the 'Company') (NASDAQ:PRAH) today announced that certain of its stockholders (the 'Selling Stockholders'), intend to offer for ...
05/04/16 08:08 AMIBB’s Mid-Cap Stocks: Kite Pharma Drug Gets Orphan Drug Status -
05/04/16 07:35 AMPRA Health Sciences, Inc. breached its 50 day moving average in a Bearish Manner : PRAH-US : May 4, 2016 -
05/04/16 06:35 AMPRA Health Sciences upgraded by Citigroup -
05/03/16 12:31 PMBUZZ-Sponsor block glut - [Reuters - UK Focus] - ** With earnings season blackouts winding down, sponsor blocks reemerge, but leave investors and investment banks licking their wounds ** Shares of CommScope Holdings, day's biggest block , slide more ...
05/02/16 06:37 PMBRIEF-PRA Health Sciences Inc announces secondary offering of 5 mln shares - * PRA Health Sciences Inc announces secondary offering of 5,000,000 shares of common stock Source text for Eikon: Further company coverage:
05/02/16 04:22 PMETF’s with exposure to PRA Health Sciences, Inc. : May 2, 2016 -
02/26/16 12:54 PMPRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2015 Results and Provides 2016 Guidance - GlobeNewswire (press release) - PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2015 Results and Provides 2016 GuidanceGlobeNewswire (press release)RALEIGH, N.C., Feb. 24, 2016 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (“PRA” or the “Company”) (NASDAQ:PRAH) today reported financial results for the quarter ended December 31, 2015. For the three months ended December 31, 2015, service ...and more »
02/26/16 12:54 PMPRA Health Sciences' (PRAH) CEO, Colin Shannon on Q4 2015 Results - Earnings Call Transcript - Welcome to the PRA Health Sciences Fourth Quarter 2015 Earnings conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session and instructions will follow at that time. If anyone should ...
02/26/16 11:05 AMHealthways Q4 Loss Narrower than Expected, Revenues Fall -
02/26/16 08:27 AMPRA Health Sciences, Inc. Earnings Analysis: 2015 By the Numbers -
02/25/16 03:46 PMEdited Transcript of PRAH earnings conference call or presentation 25-Feb-16 2:00pm GMT -
02/25/16 10:29 AMPRA HEALTH SCIENCES, INC. Files SEC form 10-K, Annual Report -
02/25/16 08:00 AMPRA Health Sciences Inc Earnings Call scheduled for 9:00 am ET today -
02/24/16 03:47 PMPRA Health Sciences beats Street 4Q forecasts -
02/24/16 03:22 PMPRA HEALTH SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and -
02/24/16 03:04 PM4:04 pm PRA Health Sciences beats by $0.09, beats on revs; guides FY16 EPS above consensus, revs above consensus -
02/24/16 06:07 AMQ4 2015 PRA Health Sciences Inc Earnings Release - After Market Close -
02/18/16 04:13 PMPRA HEALTH SCIENCES, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
02/07/16 01:40 PMPRA Health Sciences, Inc. (NASDAQ:PRAH) Brokerage Rating Update - Investor Newswire - PRA Health Sciences, Inc. (NASDAQ:PRAH) Brokerage Rating UpdateInvestor NewswirePRA Health Sciences, Inc. (NASDAQ:PRAH) has been handed a rating of 1.67 on a consensus basis by Zacks Research. Using a simplified 1 to 5 scale where 5 represents a Strong Sell and 1 a Strong Buy, 4 analysts polled by Zacks had their ratings ...and more »
02/04/16 10:58 AMPRA Health Sciences to Report Fourth Quarter 2015 Earnings - [GlobeNewswire] - RALEIGH, N.C., Feb. 04, 2016-- PRA Health Sciences, Inc. will release its fourth quarter and year end 2015 results after the market closes on Wednesday, February 24, 2016. The Company will also host a ...
02/01/16 01:35 PMCompany Shares of PRA Health Sciences, Inc. (NASDAQ:PRAH) Drops by -8.16% - Market Briefing - Company Shares of PRA Health Sciences, Inc. (NASDAQ:PRAH) Drops by -8.16%Market BriefingPRA Health Sciences, Inc. (NASDAQ:PRAH) has lost 8.16% during the past week and dropped 4.84% in the last 4 weeks. The shares has underperformed the S&P 500 by 9.74% during the past week but PRA Health Sciences, Inc. (NASDAQ:PRAH) has ...PRA Health Sciences Inc (PRAH) Given Hold Rating at Zacks Investment ResearchZolmaxall 3 news articles »
02/01/16 12:00 PMISR: Outsourced pharma research market to see accelerated growth -
01/29/16 01:32 PMPrice Target Update On PRA Health Sciences, Inc. (NASDAQ:PRAH) - Risers & Fallers - Price Target Update On PRA Health Sciences, Inc. (NASDAQ:PRAH)Risers & FallersA number of investment brokers have recently updated their price targets on shares of PRA Health Sciences, Inc. (NASDAQ:PRAH). According to the latest broker reports 5 analysts have a rating of “buy”, 1 analysts “outperform”, 3 analysts “hold”, 0 ...PRA Health Sciences, Inc. (NASDAQ:PRAH) Consensus Analyst Rating in FocusUptick Analystall 2 news articles »
About PRA Health Sciences

PRA Health Sciences logoPRA Health Sciences, Inc. is a contract research organization (CRO). The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. The Company's integrated services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. The Company's service offerings include Product Registration Services, which includes Phase IIb through III product registration trials and Phase IV trials, inclusive of post-marketing commitments and registries; Strategic Solutions, which provides Embedded Solutions and functional outsourcing services, and Early Development Services, which includes Phase I through Phase IIa clinical trials and bioanalytical laboratory services.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PRAH
  • CUSIP:
Key Metrics:
  • Previous Close: $42.01
  • 50 Day Moving Average: $45.71
  • 200 Day Moving Average: $44.59
  • P/E Ratio: 54.35
  • P/E Growth: 1.23
  • Market Cap: $2.54B
  • Current Quarter EPS Consensus Estimate: $2.43 EPS
Additional Links:
PRA Health Sciences (NASDAQ:PRAH) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha